SEER is an authoritative source of information on cancer incidence and survival in the United States. SEER currently collects and publishes cancer incidence and survival data from population-based cancer registries covering approximately 28 percent of the U.S. population.
The peripheral blood (PB) and bone marrow (BM) have more than 20% blasts, neutrophils and their precursors, plus monocytes and their precursors. The monocyte component may be more evident in the PB than in the BM.
The preliminary diagnosis may include 1. Acute myeloidleukemia (AML), NOS 2. AML with maturation 3. AML without maturation